Filip Dubovsky

Chief Tech/Sci/R&D Officer presso NOVAVAX, INC.

Patrimonio netto: 318 410 $ in data 31/03/2024

59 anni

61 relazioni

Health Technology

Consumer Services

Commercial Services

Profilo

Attualmente, Filip Dubovsky ricopre la posizione di Chief Medical Officer & Executive Vice President presso Novavax, Inc. Fa anche parte del consiglio dell'Albert B. Sabin Vaccine Institute, Inc.

Partecipazioni note in società pubbliche

Società	Data	Numero di azioni	Valorizzazione	Data di valutazione
NOVAVAX, INC. 0.05%	10/03/2024	66 613 ( 0.05% )	318 410 $	31/03/2024

Posizioni attive di Filip Dubovsky

Società	Posizione	Inizio
NOVAVAX, INC.	Chief Tech/Sci/R&D Officer	17/06/2020
Albert B. Sabin Vaccine Institute, Inc. Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC.	Director/Board Member	-

Tutte le posizioni attive di Filip Dubovsky

Precedenti posizioni note di Filip Dubovsky

Società	Posizione	Fine
ASTRAZENECA PLC	Chief Tech/Sci/R&D Officer	01/01/2020

Vedi nel dettaglio l'esperienza di Filip Dubovsky

Formazione di Filip Dubovsky

The Johns Hopkins University	Undergraduate Degree
The University of Alabama	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Filip Dubovsky

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
ASTRAZENECA PLC	Health Technology
NOVAVAX, INC.	Health Technology

Aziende private	1
Albert B. Sabin Vaccine Institute, Inc. Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC.	Commercial Services